New Brunswick adopts HPV cervical cancer testing

Human papillomavirus infection
Photo: Deposition authors: Bishop, B., Dasgupta, J., Chen, X.S.; visualization author: / Wikimedia Commons, CC BY 4.0First reported by globalnews.ca

New Brunswick officials confirmed on Wednesday that the province is shifting from traditional Pap tests to human papillomavirus (HPV) testing as the primary method for cervical cancer screening. The move aims to align provincial health practices with the World Health Organization’s global elimination goals and the federal government’s target to eradicate cervical cancer by 2040.

Transition to primary HPV screening

The HPV test detects the virus responsible for most cervical cancers with higher accuracy than the conventional Pap smear. While health-care providers in New Brunswick will initially perform the screenings in clinics, the province is also developing an at-home self-sampling option slated for implementation next year. New Brunswick Health Minister John Dornan stated that the transition is intended to improve early identification of individuals at risk, noting that the research supports early detection as a critical component of cancer prevention. Dr. Eshwar Kumar of the New Brunswick Cancer Network added that the new approach allows for more precise identification of high-risk patients, facilitating timely preventative care.

Calls for change in Nova Scotia

Following the announcement in New Brunswick, Nova Scotia’s Official Opposition is urging the provincial government to expedite a similar transition. NDP Leader Claudia Chender stated that the switch to HPV testing would benefit approximately 300,000 residents who require regular screening. Supporters of the change, including gynecologic oncologist Dr. Robert Grimshaw, argue that HPV testing is more cost-effective, less invasive, and offers superior diagnostic results compared to the current standard. Dr. Grimshaw emphasized that the ability to offer at-home testing provides patients with greater privacy while maintaining high clinical standards. Chender noted that Nova Scotia has experienced some of the highest cervical cancer rates in Atlantic Canada since 2020, arguing that the province should prioritize the adoption of more effective screening technology.

Infrastructure and implementation requirements

The Nova Scotia Department of Health and Wellness acknowledged that it is working toward adopting HPV testing as its primary screening method. However, the department indicated that the transition requires significant logistical preparation beyond simply changing the test type. Officials stated that they are currently evaluating the necessary laboratory capacity, specialized equipment, and patient follow-up systems required to support the change. The department is also reviewing the experiences of other provinces that have already implemented HPV screening, including Prince Edward Island, British Columbia, Ontario, Alberta, and Quebec. The government maintains that these infrastructure upgrades are essential to ensure that patients are properly supported from the initial screening stage through any subsequent medical care.